Novartis Investigative Site

Terni, Umbria 05100

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Lymphoma, Follicular, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early